Evofem Biosciences Inc (OTCQB:EVFM)
| 0.1399 Delayed Data As of 12:00am ET |  -0.0101 / -6.73%Today’s Change | 0.12 Today|||52-Week Range 25.00 | -98.25% Year-to-Date |
Latest EVFM News | Press Releases
No recent news for Evofem Biosciences Inc.
Today’s Trading
| Previous close | 0.15 |
| Today’s open | 0.16 |
| Day’s range | 0.12 - 0.16 |
| Volume | 128,706 |
| Average volume (3 months) | 91,618 |
| Market cap | $609.0K |
Data as of 09/25/2023
Growth & Valuation
| Earnings growth (last year) | +94.33% |
| Earnings growth (this year) | +58.96% |
| Earnings growth (next 5 years) | +30.40% |
| Revenue growth (last year) | +104.23% |
| P/E ratio | -- |
| Price/Sales | 0.22 |
| Price/Book | -- |
Competitors
| ---- | ||
| --Lattice Biologics Lt... | 0.00 | 0.00% |
| CRXMGene Biotherapeutics... | 0.00 | 0.00% |
| --Islet Holdings Inc | 0.00 | 0.00% |
Data as of 07/24/2023
Financials
| Next reporting date | November 14, 2023 |
| EPS forecast (this quarter) | -$7.50 |
| Annual revenue (last year) | $16.8M |
| Annual profit (last year) | -$76.7M |
| Net profit margin | -455.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
Chart unavailable
